Dive into the evolving research on SARS-CoV-2 in Latin America, highlighting variant surveillance, vaccine rollout, health system impacts, and regional responses to the COVID-19 pandemic.
Climate change is accelerating dengue risk across Latin America, with new high-resolution models showing that global warming could add millions of infections in the coming decades. Research from Colón-González et al. reveals that limiting warming to 1.5 °C dramatically reduces future dengue cases, shortens transmission seasons, and offers major public health benefits for Brazil, Colombia, Mexico, and other vulnerable regions.
A systematic study based on the review of 89 articles related to coronaviruses and drugs taken by patients suffering from previous diseases showed that there is no evidence for or against the use of non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen to treat patients. with COVID-19. However, he noted that other types of drugs, such as TNF blockers and JAK inhibitors, are safe to use, and IL-6 could be beneficial in treating COVID-19.
